{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T15:53:45Z","timestamp":1769097225041,"version":"3.49.0"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":2030,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shanghai Municipal Science and Technology Major Project","award":["2017SHZDZX01"],"award-info":[{"award-number":["2017SHZDZX01"]}]},{"name":"PUMC Youth Fund, and the Fundamental Research Funds for the Central Universities","award":["3332018140"],"award-info":[{"award-number":["3332018140"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670376"],"award-info":[{"award-number":["81670376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CAMS Innovation Fund for Medical Sciences","award":["2016-I2M-1-015"],"award-info":[{"award-number":["2016-I2M-1-015"]}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2017SHZDZX01"],"award-info":[{"award-number":["2017SHZDZX01"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81670376"],"award-info":[{"award-number":["81670376"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Arrhythmogenic right ventricular cardiomyopathy (ARVC) is associated with life-threatening ventricular arrhythmia and progressive ventricular dysfunction. Previous studies suggested that sex hormones play an important role in the onset and prognosis of ARVC. This study aimed to investigate the role of testosterone in predicting major adverse cardiac events in the Chinese ARVC cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Ninety-nine ARVC patients (median age, 40 years; 70.7% male) and 96 healthy controls (median age, 41 years; 62.5% male) were enrolled. The circulating levels of testosterone were measured by enzyme-linked immunosorbent assays (ELISA). The median follow-up time of all ARVC male patients was 17 months (interquartile range\/IQR 9\u201329). Cox proportional hazards regression was used to analyse the effect of plasma testosterone and other well-described risk factors on malignant arrhythmic events in male ARVC patients. The male ARVC patients had significantly elevated levels of total testosterone [TT, 6.390 (4.438\u20138.768) ng\/mL vs. 3.617 (2.073\u20134.479) ng\/mL, P &amp;lt; 0.0001, data shown as the median with IQR], bioavailable testosterone [BT, 4.11 (1.990\u20136.545) ng\/mL vs. 1.32 (0.7965\u20132.0350) ng\/mL, P &amp;lt; 0.0001, median with IQR], and free testosterone [FT, 0.2055 (0.1000\u20130.4073) ng\/mL vs. 0.0768 (0.0405\u20130.1105) ng\/mL, P &amp;lt; 0.0001, median with IQR] than healthy male volunteer, whereas no differences were observed among female counterparts. There was no significant correlation between the baseline clinical characteristics and testosterone levels in male ARVC patients (Spearman's correlation test, P &amp;gt; 0.05). During the follow-up, the levels of testosterone were higher in male patients who experienced malignant arrhythmic events (N = 22) than in those who did not (N = 25) [TT, 9.034 (7.222\u201315.370) ng\/mL vs. 4.633 (3.363\u20136.375) ng\/mL, P &amp;lt; 0.001; BT, 7.485 (2.070\u20139.163) ng\/mL vs. 3.300 (1.685\u20134.690) ng\/mL, P &amp;lt; 0.05; FT, 0.453 (0.221\u20130.758) ng\/mL vs. 0.161 (0.075\u20130.337) ng\/mL P &amp;lt; 0.05, data expressed as median (IQR) and adjusted by Dunn's multiple comparisons test], whereas such distinction was not observed among patients with significant structural progression events (N = 16). Through multivariable adjustments, the Cox regression analysis showed the level of plasma total testosterone (HR = 1.325, 95% confidence interval = 1.171\u20131.498, P &amp;lt; 0.001) was an independent predictor for malignant arrhythmic events.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The levels of plasma testosterone in ARVC male patients are higher than those in healthy males. Testosterone level, without relation to the baseline cardiac function and future significant structural progression events, is a strong predictor of future adverse arrhythmic events in male patients with ARVC. Therefore, our results suggest that testosterone may be a useful biomarker in arrhythmic risk prediction in the ARVC.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12704","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T07:02:38Z","timestamp":1590735758000},"page":"1547-1559","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Plasma Testosterone and Arrhythmic Events in Male Patients with Arrhythmogenic Right Ventricular Cardiomyopathy"],"prefix":"10.1093","volume":"7","author":[{"given":"Jie","family":"Ren","sequence":"first","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Zhang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qian","family":"Zhao","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjie","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Ruschitzka","sequence":"additional","affiliation":[{"name":"Department of Cardiology, University Heart Center, Zurich, Switzerland; Center for Integrative Human Physiology, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Firat","family":"Duru*","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]},{"name":"Department of Cardiology, University Heart Center, Zurich, Switzerland; Center for Integrative Human Physiology, University of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangping","family":"Song","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College , Beijing ,","place":["China"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"2026012115032836600_ehf212704-bib-0001","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N Engl J Med"},{"key":"2026012115032836600_ehf212704-bib-0002","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.117.309345","article-title":"Arrhythmogenic cardiomyopathy","volume":"121","author":"Corrado","year":"2017","journal-title":"Circ Res"},{"key":"2026012115032836600_ehf212704-bib-0003","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/CIRCULATIONAHA.112.001009","article-title":"Arrhythmogenic right ventricular cardiomyopathy: a challenging disease of the intercalated disc","volume":"128","author":"Saguner","year":"2013","journal-title":"Circulation"},{"key":"2026012115032836600_ehf212704-bib-0004","doi-asserted-by":"crossref","first-page":"2760","DOI":"10.1093\/eurheartj\/ehn415","article-title":"Quantitative assessment of endomyocardial biopsy in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an in vitro validation of diagnostic criteria","volume":"29","author":"Basso","year":"2008","journal-title":"Eur Heart J"},{"key":"2026012115032836600_ehf212704-bib-0005","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1016\/S0735-1097(97)00332-X","article-title":"Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: a multicenter study","volume":"30","author":"Corrado","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"2026012115032836600_ehf212704-bib-0006","first-page":"1063","article-title":"Arrhythmogenic right ventricular cardiomyopathy: implications of next-generation sequencing in appropriate diagnosis","volume":"19","author":"Medeiros-Domingo","year":"2017","journal-title":"Europace"},{"key":"2026012115032836600_ehf212704-bib-0007","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jamacardio.2016.5034","article-title":"Evaluation of structural progression in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"2","author":"Mast","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026012115032836600_ehf212704-bib-0008","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.116.003819","article-title":"Heart failure is common and under-recognized in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"10","author":"Gilotra","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2026012115032836600_ehf212704-bib-0009","first-page":"3227","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"36","author":"Corrado","year":"2015","journal-title":"Eur Heart J"},{"key":"2026012115032836600_ehf212704-bib-0010","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/CIRCIMAGING.113.000210","article-title":"Different prognostic value of functional right ventricular parameters in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"7","author":"Saguner","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"key":"2026012115032836600_ehf212704-bib-0011","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.117.030792","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"136","author":"Calkins","year":"2017","journal-title":"Circulation"},{"key":"2026012115032836600_ehf212704-bib-0012","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1093\/eurheartj\/ehz172","article-title":"A novel genotype-based clinicopathology classification of arrhythmogenic cardiomyopathy provides novel insights into disease progression","volume":"40","author":"Chen","year":"2019","journal-title":"Eur Heart J"},{"key":"2026012115032836600_ehf212704-bib-0013","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1093\/eurheartj\/ehy567","article-title":"An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis","volume":"39","author":"Chatterjee","year":"2018","journal-title":"Eur Heart J"},{"key":"2026012115032836600_ehf212704-bib-0014","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00259-010-1525-y","article-title":"Assessment of inflammation in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"37","author":"Campian","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026012115032836600_ehf212704-bib-0015","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.hrthm.2012.01.024","article-title":"Plasma BIN1 correlates with heart failure and predicts arrhythmia in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"9","author":"Hong","year":"2012","journal-title":"Heart Rhythm"},{"key":"2026012115032836600_ehf212704-bib-0016","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1080\/00015385.2017.1335371","article-title":"Galectin-3 correlates with arrhythmogenic right ventricular cardiomyopathy and predicts the risk of ventricular arrhythmias in patients with implantable defibrillators","volume":"72","author":"Oz","year":"2017","journal-title":"Acta Cardiol"},{"key":"2026012115032836600_ehf212704-bib-0017","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1161\/01.CIR.98.22.2433","article-title":"Diagnostic value of plasma levels of brain natriuretic peptide in arrhythmogenic right ventricular dysplasia","volume":"98","author":"Matsuo","year":"1998","journal-title":"Circulation"},{"key":"2026012115032836600_ehf212704-bib-0018","doi-asserted-by":"crossref","DOI":"10.4061\/2010\/919783","article-title":"C-reactive protein in arrhythmogenic right ventricular dysplasia\/cardiomyopathy and relationship with ventricular tachycardia","volume":"2010","author":"Bonny","year":"2010","journal-title":"Cardiol Res Pract"},{"key":"2026012115032836600_ehf212704-bib-0019","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/eurheartj\/ehx011","article-title":"Sex hormones affect outcome in arrhythmogenic right ventricular cardiomyopathy\/dysplasia: from a stem cell derived cardiomyocyte-based model to clinical biomarkers of disease outcome","volume":"38","author":"Akdis","year":"2017","journal-title":"Eur Heart J"},{"key":"2026012115032836600_ehf212704-bib-0020","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jacc.2009.05.039","article-title":"Testosterone: a novel therapeutic approach in chronic heart failure?","volume":"54","author":"Aukrust","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026012115032836600_ehf212704-bib-0021","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ijcard.2014.06.054","article-title":"Testosterone replacement increases aged pulmonary vein and left atrium arrhythmogenesis with enhanced adrenergic activity","volume":"176","author":"Tsai","year":"2014","journal-title":"Int J Cardiol"},{"key":"2026012115032836600_ehf212704-bib-0022","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ceca.2006.09.003","article-title":"Impact of testosterone on cardiac L-type calcium channels and Ca2+ sparks: acute actions antagonize chronic effects","volume":"41","author":"Er","year":"2007","journal-title":"Cell Calcium"},{"key":"2026012115032836600_ehf212704-bib-0023","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/biom.12968","article-title":"Power and sample size for dose-finding studies with survival endpoints under model uncertainty","volume":"75","author":"Deng","year":"2019","journal-title":"Biometrics"},{"key":"2026012115032836600_ehf212704-bib-0024","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the Task Force Criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"2026012115032836600_ehf212704-bib-0025","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ijcard.2018.06.105","article-title":"A founder homozygous DSG2 variant in East Asia results in ARVC with full penetrance and heart failure phenotype","volume":"274","author":"Chen","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026012115032836600_ehf212704-bib-0026","article-title":"Association of total testosterone, free testosterone, bioavailable testosterone, sex hormone-binding globulin, and hypertension","volume":"98","author":"Yang","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"2026012115032836600_ehf212704-bib-0027","doi-asserted-by":"crossref","first-page":"410","DOI":"10.3390\/jcm8030410","article-title":"Evolution of guidelines for testosterone replacement therapy","volume":"8","author":"Park","year":"2019","journal-title":"J Clin Med"},{"key":"2026012115032836600_ehf212704-bib-0028","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1016\/0735-1097(91)90557-P","article-title":"Testicular dysfunction with amiodarone use","volume":"18","author":"Dobs","year":"1991","journal-title":"J Am Coll Cardiol"},{"key":"2026012115032836600_ehf212704-bib-0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108742","article-title":"Very low dose spironolactone protects experimentally-induced polycystic ovarian syndrome from insulin-resistant metabolic disturbances by suppressing elevated circulating testosterone","volume":"310","author":"Adeyanju","year":"2019","journal-title":"Chem Biol Interact"},{"key":"2026012115032836600_ehf212704-bib-0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13293-015-0027-9","article-title":"Testosterone modulates cardiac contraction and calcium homeostasis: cellular and molecular mechanisms","volume":"6","author":"Ayaz","year":"2015","journal-title":"Biol Sex Differ"},{"key":"2026012115032836600_ehf212704-bib-0031","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jacc.2015.12.005","article-title":"Testosterone and cardiovascular disease","volume":"67","author":"Kloner","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026012115032836600_ehf212704-bib-0032","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/CIRCGENETICS.113.000288","article-title":"Compound and digenic heterozygosity predicts lifetime arrhythmic outcome and sudden cardiac death in desmosomal gene-related arrhythmogenic right ventricular cardiomyopathy","volume":"6","author":"Rigato","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"2026012115032836600_ehf212704-bib-0033","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nature11799","article-title":"Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs","volume":"494","author":"Kim","year":"2013","journal-title":"Nature"},{"key":"2026012115032836600_ehf212704-bib-0034","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1016\/j.hrthm.2014.08.031","article-title":"Sex hormone levels in patients with sudden cardiac arrest","volume":"11","author":"Narayanan","year":"2014","journal-title":"Heart Rhythm"},{"key":"2026012115032836600_ehf212704-bib-0035","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/europace\/euv313","article-title":"Sex-dependent alterations of Ca2+ cycling in human cardiac hypertrophy and heart failure","volume":"18","author":"Fischer","year":"2016","journal-title":"Europace"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12704","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ehf2.12704","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ehf2.12704","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/4\/1547\/65901870\/eschf_7_4_1547.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/7\/4\/1547\/65901870\/eschf_7_4_1547.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:04:04Z","timestamp":1769025844000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/7\/4\/1547\/8372699"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":35,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,5,29]]},"published-print":{"date-parts":[[2020,8,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12704","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,8]]},"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"2019-09-18","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-30","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-05-29","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}